Reshaping immunotherapy sequencing strategy: equivalent survival with induction plus consolidation vs. consolidation-only strategy in unresectable stage III NSCLC.

Oncoimmunology · 2026 · PMC13182959 · PMID 42141789

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an unfavorable trendno p-value reported

After PSM, this difference was no longer statistically significant ( p = 0.130), but the group still showed an unfavorable trend (HR = 1.62).

also in 104 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.